Skip to main content
. 2023 Jan 2;42(1):111895. doi: 10.1016/j.celrep.2022.111895

Figure 2.

Figure 2

Activated PD-1highCXCR5 Tph cells are significantly increased in non-ICU patients with COVID-19

(A) Venn diagrams showing the overlapped genes among those significantly upregulated (log2FC > 1, FDR < 0.05) (left) and downregulated (log2FC < −1, FDR < 0.05) (right) in PD-1highCXCR5 Tph cells compared with five subsets.

(B) Heatmap of PD-1highCXCR5 Tph cell-related genes (selected in A).

(C) Heatmap of PD-1highCXCR5 Tph cell-related genes (selected in A) among each T cell cluster of our scRNA-seq dataset reported.5

(D) Representative data for each T cell subset among HLA-DR+CD38+CD45RACD4+ T cells (left), and their proportions were evaluated by one-way ANOVA with Dunn’s multiple comparisons tests (right). COVID-19 samples that have more than 5% of HLA-DR+CD38+ T cells were evaluated (n = 11).

(E) Representative data of HLA-DR+CD38+ activated cells in PD-1highCXCR5 Tph cells between non-ICU and ICU patients (left). The proportions of activated PD-1highCXCR5 Tph cells were evaluated (non-ICU; n = 56, ICU; n = 36) by two-tailed unpaired Student’s t test (right).

(F and G) Each T cell subset and autologous CD20+CD27+ B cells were co-cultured (n = 7, patients with COVID-19). Representative data of CD27highCD138+ plasma cells after co-culture (F, left) and the proportion of plasma cells (F, right). IgG concentrations in supernatants were evaluated (G). PD-1int/−CXCR5 T cells indicate both PD-1intCXCR5 T cells (subset iii) and PD-1CXCR5 T cells (v).

Data are represented as mean ± SEM (D–G).

See also Figure S4.